Lack of EGF receptor contributes to drug sensitivity of human germline cells

British Journal of Cancer

Volumn 92, Issue 2, 2005, Pages 334-341

  Park, S J ^a,b   Armstrong, S ^a   Kim, C H ^a   Yu, M ^a   Robertson, K ^a   Kelley, M R ^a   Lee, S H ^a,b  

^a INDIANA UNIVERSITY   (United States)

^b INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Cancer chemotherapy; Cisplatin; DNA damage; Drug resistance; Epidermal growth factor receptor

Indexed keywords

CYCLINE; DNA; DNA DEPENDENT PROTEIN KINASE; EPIDERMAL GROWTH FACTOR RECEPTOR; KU ANTIGEN; PROTEIN; PROTEIN KU 80; TRANSCRIPTION FACTOR IIH; UNCLASSIFIED DRUG;

ARTICLE; CANCER CELL; CONTROLLED STUDY; DNA DAMAGE; DNA REPAIR; DRUG SENSITIVITY; GENE MUTATION; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; INTERMETHOD COMPARISON; OVARY CANCER; PRIORITY JOURNAL; PROTEIN EXPRESSION; STATISTICAL SIGNIFICANCE; TUMOR CELL;

BLOTTING, WESTERN; DNA REPAIR; DNA REPAIR ENZYMES; DRUG RESISTANCE, NEOPLASM; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; NEOPLASMS, GERM CELL AND EMBRYONAL; OVARIAN NEOPLASMS; RECEPTOR, EPIDERMAL GROWTH FACTOR; TUMOR CELLS, CULTURED;

EID: 14844338449     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjc.6602315     Document Type: Article

References (68)

1. Adler V, Franklin C, Kraft A (1992) Phorbol ester stimulate the phosphorylation of c-Jun but not v-Jun: regulation by the N-terminal delta domain. Proc Natl Acad Sci USA 89: 5341-5345
2. Asagoshi K, Yamada T, Terato H, Ohyama Y, Monden Y, Arai T, Nishimura S, Aburatani H, Lindahl T, Ide H (2000) Distinct repair activities of human 7,8-dihydro-8-oxoguanine DNA glycosylase and formamidopyrimidine DNA glycosylase for formamidopyrimidine and 7,8-dihydro-8-oxoguanine. J Biol Chem 275: 4956-4964
3. Arteaga C (2003) Targeting HER1/EGFR: a molecular approach to cancer therapy. Semin Oncol 30: 3-14
4. Baekelandt M, Kristensen GB, Trope CG, Nesland JM, Holm R (1999) Epidermal growth factor receptor expression has no independent prognostic significance in advanced ovarian cancer. Anticancer Res 19: 4469-4474
5. Bielas JH, Heddle JA (2000) Proliferation is necessary for both repair and mutation in transgenic mouse cells. Proc Natl Acad Sci USA 97: 11391-11396
6. Bruell D, Stocker M, Huhn M, Redding N, Kupper M, Schumacher P, Paetz A, Bruns CJ, Haisma HJ, Fischer R, Finnern R, Barth S (2003) The recombinant anti-EGF receptor immunotoxin 425(scFv)-ETA' suppresses growth of a highly metastatic pancreatic carcinoma cell line. Int J Oncol 23: 1179-1186
7. Cagnoli M, Alama A, Barbieri F, Novelli F, Bruzzo C, Sparatore F (1998) Synthesis and biological activity of gold and tin compounds in ovarian cancer cells. Anticancer Drugs 9(7): 603-610
8. Chetsanga CJ, Lindahl T (1979) Release of 7-methylguanine residues whose imidazole rings have been opened from damaged DNA by a DNA glycosylase from Escherichia coli. Nucleic Acids Res 6: 3673-3684
9. Cohen NA, Egorin MJ, Snyder SW, Ashar B, Wietharn BE, Pan SS, Ross DD, Hilton J (1991) Interaction of N,N′,N″-triethylenethiophosphoramide and N,N′,N″-triethylenephosphoramide with cellular DNA. Cancer Res 51: 4360-4366
10. Demple B, Harrison L (1994) Repair of oxidative damage to DNA: enzymology and biology. Annu Rev Biochem 63: 915-948
11. Deutsch WA, Yacoub A, Jaruga P, Zastawny TH, Dizdaroglu M (1997) Characterization and mechanism of action of Drosophila ribosomal protein S3 DNA glycosylase activity for the removal of oxidatively damaged DNA bases. J Biol Chem 272: 32857-32860
12. Dinapoli RP, Brown LD, Arusell RM, Earle JD, O'Fallon JR, Buckner JC (1993) Phase III comparative evaluation of PCNU and carmustine combined with radiation therapy for high-grade glioma. J Clin Oncol 11: 1316-1321
13. Dixit M, Yang JL, Poirier MC, Price JO, Andrews PA, Arteaga CL (1997) Abrogation of cisplatin-induced programmed cell death in human breast cancer cells by epidermal growth factor antisense RNA. J Natl Cancer Inst 89: 365-373
14. Dobson AW, Xu Y, Kelley MR, LeDoux SP, Wilson GL (2000) Enhanced mtDNA repair and cellular survival following oxidative stress by targeting the hOGG repair enzyme to mitochondria. J Biol Chem 275: 37518-37523
15. Doetsch PW, Cunningham RP (1990) The enzymology of apurinic/apyrimidinic endonucleases. Mutat Res 236: 173-201
16. Drummond JT, Anthoney A, Brown R, Modrich P (1996) Cisplatin and adriamycin resistance are associated with MutLα and mismatch repair deficiency in an ovarian tumor cell line. J Biol Chem 271: 19645-19648
17. Duyster J, Baskaran R, Wang JY (1995) Src homology 2 domain as a specificity determinant in the c-Abl-mediated tyrosine phosphorylation of the RNA polymerase II carboxyl-terminal repeated domain. Proc Natl Acad Sci USA 92: 1555-1559
18. Eastman A, Schulte N (1998) Enhanced DNA repair as a mechanism of resistance to cis-diammine-dichloroplatinum (II). Biochemistry 27: 4730-4734
19. Evans AR, Limp-Foster M, Kelley MR (2000) Going APE over ref-1. Mutat Res 461: 83-108
20. Ferrera CG, Tols C, Gaccone G (1999) p53 and chemosensitivity. Ann Oncol 10: 1011-1021
21. Fink D, Nebel S, Aebi S, Zheng H, Cenni B, Nehme A (1996) The role of DNA mismatch repair in platinum drug resistance. Cancer Res 56: 4881-4886
22. Fink D, Aebi S, Howell SB (1998) The role of DNA mismatch repair in drug resistance. Clin Cancer Res 4: 1-6
23. Fishel R, Kolodner RD (1995) Identification of mismatch repair genes and their role in the development of cancer. Curr Opin Genet Dev 5: 382-395
24. Foltz IN, Gerl RE, Wieler JS, Luckach M, Salmon RA, Schrader JW (1998) Human mitogen-activated protein kinase kinase 7 (MKK7) is a highly conserved c-Jun N-terminal kinase/stress-activated protein kinase (JNK/ SAPK) activated by environmental stresses and physiological stimuli. J Biol Chem 274: 9344-9351
25. Garcia I, del Casar JM, Corte MD, Allende MT, Garcia-Muniz JL, Vizoso F (2003) Epidermal growth factor receptor and c-erbB-2 contents in unresectable (UICC R1 or R2) gastric cancer. Int J Biol Markers 18: 200-206
26. Gill RD, Cussac C, Souhami RL, Laval F (1996) Increased resistance to N,N′,N″-triethylenethiophosphoramide (thiotepa) in cells expressing the Escherichia coli formamidopyrimidine-DNA glycosylase. Cancer Res 56: 3721-3724
27. Graves RJ, Felzenszwalb I, Laval J, O'Connor TR (1992) Excision of 5′-terminal deoxyribose phosphate from damaged DNA is catalyzed by the Fpg protein of Escherichia coli. J Biol Chem 267: 14429-14435
28. Haedicke W, Popper HH, Buck CR, Zatloukal K (2003) Automated evaluation and normalization of immunohistochemistry on tissue microarrays with a DNA microarray scanner. Biotechniques 35(1): 164-168
29. Hansen WK, Deutsch WA, Yacoub A, Xu Y, Williams DA, Kelley MR (1998) Creation of a fully functional human chimeric DNA repair protein. Combining O6-methylguanine DNA methyltransferase (MGMT) and AP endonuclease (APE/redox effector factor 1; Ref1) DNA repair proteins. J Biol Chem 273: 756-762
30. Hansen WK, Kelley MR (2000) Review of mammalian DNA repair and translational implications. J Pharmacol Exp Ther 295: 1-9
31. Heimberger AB, Crotty LE, Archer GE, Hess KR, Wikstrand CJ, Friedman AH, Friedman HS, Bigner DD, Sampson JH (2003) Epidermal growth factor receptor VIII peptide vaccination is efficacious against established intracerebral tumors. Clin Cancer Res 9(11): 4247-4254
32. Hoffmann M, Schmidt M, Wels W (1998) Activation of EGF receptor family members suppresses the cytotoxic effects of tumor necrosis factor-alpha. Cancer Immunol Immunother 47: 167-175
33. Hui AB, Lo KW, Yin XL, Poon WS, Ng HK (2001) Detection of multiple gene amplifications in glioblastoma multiforme using array-based comparative genomic hybridization. Lab Invest 81: 717-723
34. Johnson SW, Perez RP, Godwin AK, Yeung AT, Handel LM, Ozols RF, Hamilton TC (1994) Role of platinum-DNA adduct formation and removal in cisplatin resistance in human ovarian cancer cell lines. Biochem Pharmacol 47: 689-697
35. Karahalil B, Girard PM, Boiteux S, Dizdaroglu M (1998) Substrate specificity of the Ogg1 protein of Saccharomyces cerevisiae: excision of guanine lesions produced in DNA by ionizing radiation- or hydrogen peroxide/metal ion-generated free radicals. Nucleic Acids Res 26: 1228-1233
36. Koi M, Umar A, Chauhan DP, Cherian SP, Carethers JM, Kunkel TA, Boland CR (1994) Human chromosome 3 corrects mismatch repair deficiency and microsatellite instability and reduces N-methyl-N′-nitro-N- nitrosoguanidine tolerance in colon tumor cells with homozygous hMLH1 mutation. Cancer Res 54: 4308-4312
37. Kuga T, Sakamaki S, Matsunaga T, Hirayama Y, Kuroda H, Takahashi Y, Kusakabe T, Kato I, Niitsu Y (1997) Fibronectin fragment-facilitated retroviral transfer of the glutathione-S-transferase pi gene into CD34+ cells to protect them against alkylating agents. Hum Gene Ther 8: 1901-1910
38. Laemmli UK (1970) Cleavage of structural proteins during assembly of the head of bacteriophage T4. Nature 227: 680-685
39. Lai GM, Ozols RF, Smyth JF, Young RF, Hamilton TC (1988) Enhanced DNA repair and resistance to cisplatin in human ovarian cancer. Biochem Pharmacol 37: 4597-4600
40. Lei W, Mayotte JE, Levitt ML (1999) Enhancement of chemosensitivity and programmed cell death by tyrosine kinase inhibitors correlates with EGFR expression in non-small cell lung cancer cells. Anticancer Res 19: 221-228
41. Leighton C, Fisher B, Bauman G, Depiero S, Stitt L, Macdonald D, Cairncross G (1997) Supratentorial low-grade gliomas in adults: an analysis of prognostic factors and timing of radiation. J Clin Oncol 15: 1294-1301
42. Leung SY, Yuen ST, Chan TL, Chan AS, Ho JW, Kwan K, Fan YW, Hung KN, Chung LP, Wyllie AH (2000) Chromosomal instability and p53 inactivation are required for genesis of glioblastoma but not for colorectal cancer in patients with germline mismatch repair gene mutation. Oncogene 19: 4079-4083
43. Liang K, Ang KK, Milas L, Hunter N, Fan Z (2003) The epidermal growth factor receptor mediates radioresistance. Int J Radiat Oncol Biol Phys 57(1): 246-254
44. Limp-Foster M, Kelley MR (2000) DNA repair and gene therapy. implications for translational uses. Environ Mol Mutagen 35: 71-81
45. Litz-Jackson S, Miller AH, Burgess GS, Boswell HS (1992) Dissociation of nuclear events on p21 RAS transformation of FDC-P1 myeloid cells; c-jun/AP1 expression versus c-myc transcription. Blood 79: 2404-2414
46. Lydon NB, Mett H, Mueller M, Becker M, Cozens RM, Stover D, Daniels D, Traxler P, Buchdunger E (1998) A potent protein-tyrosine kinase inhibitor which selectively blocks proliferation of epidermal growth factor receptor-expressing tumor cells in vitro and in vivo. Int J Cancer 76: 154-163
47. Mello JA, Acharya S, Fishel R, Essigmann JM (1996) The mismatch-repair protein hMSH2 binds selectively to DNA adducts of the anticancer drug cisplatin. Chem Biol 3: 579-589
48. Mitra S, Hazra TK, Roy R, Ikeda S, Biswas T, Lock J, Boldogh I, Izumi T (1997) Complexities of DNA base excision repair in mammalian cells. Mol Cell 7: 305-312
49. Modjtahedi H, Affleck K, Stubberfield C, Dean C (1998) EGFR blockade by tyrosine kinase inhibitor or monoclonal antibody inhibits growth, directs terminal differentiation and induces apoptosis in the human squamous cell carcinoma HN5. Int J Oncol 13: 335-342
50. Mohrenweiser HW, Wilson III DM, Jones IM (2003) Challenges and complexities in estimating both the functional impact and the disease risk associated with the extensive genetic variation in human DNA repair genes. Mutat Res 526: 93-125
51. O'Neill JP (2000) DNA damage, DNA repair, cell proliferation, and DNA replication: how do gene mutations result? Proc Natl Acad Sci USA 97: 11137-11139
52. Park S-J, Oh E-J, Yoo M-A, Lee S-H (2001) Involvement of DNA-dependent protein kinase in regulation of stress-induced JNK activation. DNA Cell Biol 20: 637-645
53. Perez M, Donato NJ (1996) Activation of epidermal growth factor receptor tyrosine phosphorylation by tumor necrosis factor correlates with loss of cytotoxic activity. J Interferon Cytokine Res 16: 307-314
54. Robertson KA, Bullock HA, Xu Y, Tritt R, Zimmerman E, Ulbright TM, Foster RS, Einhorn LH, Kelley MR (2001) Altered expression of Ape1/ref-1 in germ cell tumors and overexpression in NT2 cells confers resistance to bleomycin and radiation. Cancer Res 61: 2220-2225
55. Rosenquist TA, Zharkov DO, Grollman AP (1997) Cloning and characterization of a mammalian 8-oxoguanine DNA glycosylase. Proc Natl Acad Sci USA 94: 7429-7434
56. Roulston A, Reinhard C, Amiri P, Williams LT (1998) Early activation of c-Jun N-terminal kinase and p38 kinase regulates cell survival in response to tumor necrosis factor alpha. J Biol Chem 273: 10232-10239
57. Schreiner B, Greten FR, Baur DM, Fingerle AA, Zechner U, Bohm C, Schmid M, Hameister H, Schmid RM (2003) Murine pancreatic tumor cell line TD2 bears the characteristic pattern of genetic changes with two independently amplified gene loci. Oncogene 22: 6802-6809
58. She Y, Lee F, Chen J, Haimovitz-Friedman A, Miller VA, Rusch VR, Kris MG, Sirotnak FM (2003) The epidermal growth factor receptor tyrosine kinase inhibitor ZD1839 selectively potentiates radiation response of human tumors in nude mice, with a marked improvement in therapeutic index. Clin Cancer Res 9: 3773-3778
59. Shintani S, Kiyota A, Mihara M, Sumida T, Kayahara H, Nakashiro KI, Hamakawa H (2003) Enhancement of radiosensitivity in head and neck cancer cells by ZD1839 ('IRESSA'), a selective epidermal growth factor receptor tyrosine kinase inhibitor. Am J Clin Oncol 26(5): E150-E156
60. Skacel M, Ormsby AH, Pettay JD, Tsiftsakis EK, Liou LS, Klein EA, Levin HS, Zippe CD, Tubbs RR (2001) Aneusomy of chromosomes 7, 8, and 17 and amplification of HER-2/neu and epidermal growth factor receptor in Gleason score 7 prostate carcinoma: a differential fluorescent in situ hybridization study of Gleason pattern 3 and 4 using tissue microarray. Hum Pathol 32: 1392-1397
61. Stigger E., Drissi R., Lee S-H (1998) Functional analysis of human replication protein A in nucleotide excision repair. J Biol Chem 273: 9337-9343
62. Umar A, Koi M, Risinger JI, Glaab WE, Tindall KR, Kolodner RD, Boland CR, Barrett JC, Kunkel TA (1997) Correction of hypermutability, N-methyl-N′-nitro-N-nitrosoguanidine resistance, and defective DNA mismatch repair by introducing chromosome 2 into human tumor cells with mutations in MSH2 and MSH6. Cancer Res 57: 3949-3955
63. van Puijenbroek AA, van Weering DH, van den Brink CE, Bos JL, van der Saag PT, de Laat SW, den Hertog J (1997) Cell scattering of SK-N-MC neuroepithelioma cells in response to Ret and FGF receptor tyrosine kinase activation is correlated with sustained ERK2 activation. Oncogene 14: 1147-1157
64. Wang X, Huong SM, Chiu ML, Raab-Traub N, Huang ES (2003) Epidermal growth factor receptor is a cellular receptor for human cytomegalovirus. Nature 424(6947): 456-461
65. Waters TR, Gallinari P, Jiricny J, Swann PF (1999) Human thymine DNA glycosylase binds to apurinic sites in DNA but is displaced by human apurinic endonuclease 1. J Biol Chem 274: 67-74
66. Witters L, Kumar R, Mandal M, Bennett CF, Miraglia L, Lipton A (1999) Antisense oligonucleotides to the epidermal growth factor receptor. Breast Cancer Res Treat 53: 41-50
67. Zhang HT, Wang Q, Greene MI, Murali R (2000) New perspectives on anti-HER2/neu therapeutics. Drug News Perspect 13(6): 325-329
68. Zharkov DO, Rosenquist TA, Gerchman SE, Grollman AP (2000) Substrate specificity and reaction mechanism of murine 8-oxoguanine-DNA glycosylase. J Biol Chem 275: 28607-28617